- Home
- /
- Drugs
- /
- V
- /
- Voriconazole
- /
- VORICONAZOLE VORICONAZOLE 10 mg/mL Zydus Lifesciences Limited
VORICONAZOLE
- VORICONAZOLE VORICONAZOLE 10 mg/mL Zydus Lifesciences Limited
- VORICONAZOLE VORICONAZOLE 10 mg/mL Zydus Pharmaceuticals USA Inc.
- Voriconazole VORICONAZOLE 10 mg/mL Fosun Pharma USA Inc.
- Voriconazole VORICONAZOLE 10 mg/mL Fresenius Kabi USA, LLC
- Voriconazole VORICONAZOLE 10 mg/mL XGen Pharmaceuticals DJB, Inc.
- Voriconazole VORICONAZOLE 10 mg/mL Civica, Inc.
- VFEND VORICONAZOLE 10 mg/mL Roerig
- Voriconazole VORICONAZOLE 10 mg/mL Gland Pharma Limited
- Voriconazole VORICONAZOLE 10 mg/mL Civica, Inc.
- Voriconazole VORICONAZOLE 10 mg/mL Xellia Pharmaceuticals USA LLC
- Voriconazole VORICONAZOLE 10 mg/mL XGen Pharmaceuticals DJB, Inc.
- VFEND VORICONAZOLE 10 mg/mL Roerig
- Voriconazole VORICONAZOLE 10 mg/mL Eugia US LLC
- Voriconazole VORICONAZOLE 10 mg/mL Meitheal Pharmaceuticals Inc.
- VFEND VORICONAZOLE 10 mg/mL Roerig
- Voriconazole VORICONAZOLE 10 mg/mL UBI Pharma Inc.
- Voriconazole VORICONAZOLE 10 mg/mL Sandoz Inc
Summary of product characteristics
Effective Time
20221105
Version
4
Spl Product Data Elements
VORICONAZOLE voriconazole VORICONAZOLE VORICONAZOLE SULFOBUTYLETHER .BETA.-CYCLODEXTRIN
Application Number
ANDA208983
Brand Name
VORICONAZOLE
Generic Name
voriconazole
Product Ndc
70771-1413
Product Type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Container Label NDC 70771-1413-1 Voriconazole for Injection 200 mg per vial Sterile Single-Dose Vial For Intravenous Infusion Only Rx Only PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Carton Label NDC 70771-1413-1 Voriconazole for Injection 200 mg per vial Sterile Single-Dose Vial For Intravenous Infusion Only 1 Vial Rx Only figure02 figure03
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.